Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)
Condition:   CandidiasisIntervention:   Drug: MK0991, caspofungin acetate/Duration of Treatment: variableSponsor:   Merck Sharp & Dohme Corp.Completed - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 20, 2004 Category: Research Source Type: clinical trials